Vitiligo is an acquired idiopathic hypomelanotic disorder in which localized areas are devoid of melanocytes, resulting in depigmented macules which are often symmetrically distributed. Skin specialist in Delhi assumes the disease has 1-3% worldwide prevalence, with no predilection for age, sex, or race. About 50% of cases start before 20 years of age. Vitiligo can be quite psychologically and socially distressing, and in some cultures results in affected individuals being ostracized. This can lead to severe impairment of a patient’s life, particularly if the visible areas of the body (face, hands) are involved. Because of lack of melanin pigment there is an increased risk of sunburn and a theoretic increased risk of skin cancer in the amelanotic areas, and there is an association with ocular abnormalities, especially iritis.
Specific Investigetions
- Antinuclear antibodies (ANA)
- Complete blood count with indices
- Fasting blood glucose
- Thyroid- stimulating hormone (TSH) and thyroid auto antibodies
- Immunohistopathology of skin
First- Line Therapy
- Topical corticosteroids
- Topical photochemotherapy
- Systemic photochemotherapy
- Narrowband UVB (NBUVB)
- 308- nm excimer laser Skin n laser centre has all the facilities and expert skin specialists to cure this condition.